A Look At Aclaris Therapeutics Inc (NASDAQ: ACRS): How Much Is It Worth And How Should It Be Assessed?
Aclaris Therapeutics Inc (NASDAQ:ACRS)’s traded shares stood at 1.29 million during the last session, with the company’s beta value hitting 0.23. At the close of